Developing a Digital Medication Adherence Intervention for and With Patients With Asthma and Low Health Literacy: Protocol for a Participatory Design Approach.
asthma
eHealth
health care
health literacy
low health literacy
mHealth
medication
medication adherence
participatory design
participatory medicine
Journal
JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394
Informations de publication
Date de publication:
12 Apr 2023
12 Apr 2023
Historique:
received:
11
01
2022
accepted:
27
12
2022
revised:
21
12
2022
medline:
13
4
2023
entrez:
12
4
2023
pubmed:
13
4
2023
Statut:
epublish
Résumé
Current eHealth interventions are poorly adopted by people with low health literacy (LHL) as they often fail to meet their needs, skills, and preferences. A major reason for this poor adoption is the generic, one-size-fits-all approach taken by designers of these interventions, without addressing the needs, skills, and preferences of disadvantaged groups. Participatory design approaches are effective for developing interventions that fit the needs of specific target groups; yet, very little is known about the practical implications of executing a participatory design project for and with people with LHL. This study aimed to demonstrate the application of participatory design activities specifically selected to fit the needs and skills of people with LHL and how these were manifested within an overarching eHealth design process. In addition, the study aims to present reflections and implications of these activities that could support future designers to engage people with LHL in their design processes. We used the design process of a smart asthma inhaler for people with asthma and LHL to demonstrate participatory design activities. The study was framed under 5 stages of design thinking: empathize, define, ideate, prototype, and test within 2 major iteration cycles. We integrated 3 participatory design activities deemed specifically appropriate for people with LHL: co-constructing stories, experience prototype exhibition, and video prototype evaluation. Co-constructing stories was found to deepen the understanding of the participant's motivation to use or not to use maintenance medication. This understanding informed and facilitated the subsequent development of diverse preliminary prototypes of possible interventions. Discussing these prototypes in the experience prototype exhibition helped provoke reactions, thoughts, and feelings about the interventions, and potential scenarios of use. Through the video prototype evaluation, we were able to clearly communicate the goal and functionality of the final version of our intervention and gather appropriate responses from our participants. This study demonstrates a participatory design approach for and with patients with asthma and LHL. We demonstrated that careful consideration and selection of activities can result in participants that are engaged and feel understood. This paper provides insight into the practical implications of participatory activities with people with LHL and supports and inspires future designers to engage with this disadvantaged target group.
Sections du résumé
BACKGROUND
BACKGROUND
Current eHealth interventions are poorly adopted by people with low health literacy (LHL) as they often fail to meet their needs, skills, and preferences. A major reason for this poor adoption is the generic, one-size-fits-all approach taken by designers of these interventions, without addressing the needs, skills, and preferences of disadvantaged groups. Participatory design approaches are effective for developing interventions that fit the needs of specific target groups; yet, very little is known about the practical implications of executing a participatory design project for and with people with LHL.
OBJECTIVE
OBJECTIVE
This study aimed to demonstrate the application of participatory design activities specifically selected to fit the needs and skills of people with LHL and how these were manifested within an overarching eHealth design process. In addition, the study aims to present reflections and implications of these activities that could support future designers to engage people with LHL in their design processes.
METHODS
METHODS
We used the design process of a smart asthma inhaler for people with asthma and LHL to demonstrate participatory design activities. The study was framed under 5 stages of design thinking: empathize, define, ideate, prototype, and test within 2 major iteration cycles. We integrated 3 participatory design activities deemed specifically appropriate for people with LHL: co-constructing stories, experience prototype exhibition, and video prototype evaluation.
RESULTS
RESULTS
Co-constructing stories was found to deepen the understanding of the participant's motivation to use or not to use maintenance medication. This understanding informed and facilitated the subsequent development of diverse preliminary prototypes of possible interventions. Discussing these prototypes in the experience prototype exhibition helped provoke reactions, thoughts, and feelings about the interventions, and potential scenarios of use. Through the video prototype evaluation, we were able to clearly communicate the goal and functionality of the final version of our intervention and gather appropriate responses from our participants.
CONCLUSIONS
CONCLUSIONS
This study demonstrates a participatory design approach for and with patients with asthma and LHL. We demonstrated that careful consideration and selection of activities can result in participants that are engaged and feel understood. This paper provides insight into the practical implications of participatory activities with people with LHL and supports and inspires future designers to engage with this disadvantaged target group.
Identifiants
pubmed: 37043260
pii: v7i1e35112
doi: 10.2196/35112
pmc: PMC10134023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e35112Informations de copyright
©Jasper S Faber, Charlotte C Poot, Tessa Dekkers, Natalia Romero Herrera, Niels H Chavannes, Eline Meijer, V T Visch. Originally published in JMIR Formative Research (https://formative.jmir.org), 12.04.2023.
Références
JMIR Hum Factors. 2022 Oct 6;9(4):e41481
pubmed: 36102548
PLoS One. 2015 Apr 27;10(4):e0123937
pubmed: 25915420
J Clin Med. 2020 Feb 28;9(3):
pubmed: 32121180
Patient Educ Couns. 2013 Aug;92(2):273-8
pubmed: 23523196
J Allergy Clin Immunol. 2012 Apr;129(4):935-42
pubmed: 22326486
J Med Internet Res. 2011 Dec 05;13(4):e103
pubmed: 22138112
J Health Commun. 2016;21(sup2):69-82
pubmed: 27662265
J Allergy Clin Immunol. 2013 Aug;132(2):321-7
pubmed: 23591273
Eur J Gen Pract. 2019 Oct;25(4):179-189
pubmed: 31597502
Chron Respir Dis. 2019 Jan-Dec;16:1479973118816418
pubmed: 30789021
Br J Health Psychol. 2013 Sep;18(3):469-73
pubmed: 23724956
J Asthma. 2018 Sep;55(9):1018-1027
pubmed: 29064746
J Med Internet Res. 2010 Feb 17;12(1):e4
pubmed: 20164043
J Am Pharm Assoc (2003). 2012;52(6):823-6
pubmed: 23229971
Int J Med Inform. 2014 Dec;83(12):967-74
pubmed: 25269992
BMC Med. 2019 Apr 29;17(1):84
pubmed: 31030670
J Transcult Nurs. 2007 Apr;18(2):150-6
pubmed: 17416717
Thorax. 2012 Aug;67(8):751-3
pubmed: 22436168
BMC Public Health. 2018 Apr 2;18(1):432
pubmed: 29609576
J Med Internet Res. 2020 Apr 13;22(4):e17342
pubmed: 32281936
J Med Internet Res. 2021 Jan 8;23(1):e18901
pubmed: 33416501
J Clin Res Bioeth. 2014 Apr 5;5(3):178
pubmed: 25133065
Int J Environ Res Public Health. 2020 Apr 16;17(8):
pubmed: 32316344
Res Nurs Health. 1996 Dec;19(6):525-9
pubmed: 8948406
J Med Internet Res. 2015 Feb 24;17(2):e52
pubmed: 25803266
Health Promot Int. 2001 Jun;16(2):207-14
pubmed: 11356759
Eur J Public Health. 2015 Dec;25(6):1053-8
pubmed: 25843827
Front Digit Health. 2021 Jul 08;3:690182
pubmed: 34713165
Clin Transl Allergy. 2017 Nov 10;7:39
pubmed: 29152167
Prev Chronic Dis. 2018 Sep 27;15:E117
pubmed: 30264690
J Med Internet Res. 2011 Dec 05;13(4):e111
pubmed: 22155738
J Med Internet Res. 2021 Sep 9;23(9):e26434
pubmed: 34499039
J Gen Intern Med. 2006 Aug;21(8):813-7
pubmed: 16881939
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
J Med Internet Res. 2014 Feb 18;16(2):e51
pubmed: 24550161
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
J Med Internet Res. 2020 Apr 27;22(4):e13780
pubmed: 32338617
J Nurs Scholarsh. 2003;35(3):207
pubmed: 14562485
Pharm Pract (Granada). 2016 Apr-Jun;14(2):686
pubmed: 27382421
J Allergy Clin Immunol. 2017 Mar;139(3):804-809
pubmed: 27555454
Respir Med. 2019 Mar;149:59-68
pubmed: 30803887
J Community Health. 2009 Aug;34(4):321-7
pubmed: 19353250
J Med Internet Res. 2019 Aug 19;21(8):e12972
pubmed: 31429415
Stud Health Technol Inform. 2017;240:303-329
pubmed: 28972525
Control Clin Trials. 2001 Dec;22(6 Suppl):236S-43S
pubmed: 11728627
Mayo Clin Proc. 2011 Apr;86(4):304-14
pubmed: 21389250